4.7 Article

Four Main Virotypes among Extended-Spectrum-β-Lactamase-Producing Isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, Epidemiological, and Clinical Characteristics

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 51, 期 10, 页码 3358-3367

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01555-13

关键词

-

资金

  1. Ramon y Cajal program from the Spanish Ministerio de Economia y Competitividad, Gobierno de Espana
  2. Agencia Espanola de Cooperacion Internacional (AECI) (Ministerio de Asuntos Exteriores y de Cooperacion)
  3. Red Espanola de Investigacion en Patologia Infecciosa (REIPI) [RD06/0008/1018-1016, RD12/0015]
  4. Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana [PI09/01273, 070190, 10/02021, 10/01955, 10/00795, PI11/01117]
  5. Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [CN2012/303 09TAL007261PR]
  6. European Regional Development Fund [ERDF] [10MRU261023PR]
  7. Junta de Andalucia [0048/2008, CTS-5259]
  8. Spanish Ministry of Education [BFU2011-26608]
  9. European VII Framework Program [282004/FP7-HEALTH.2011.2.3.1-2]
  10. FEDER-INNTERCONECTA-COLIVAC
  11. Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]

向作者/读者索取更多资源

A total of 1,021 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBLEC) isolates obtained in 2006 during a Spanish national survey conducted in 44 hospitals were analyzed for the presence of the O25b:H4-B2-ST131 (sequence type 131) clonal group. Overall, 195 (19%) O25b-ST131 isolates were detected, with prevalence rates ranging from 0% to 52% per hospital. Molecular characterization of 130 representative O25b-ST131 isolates showed that 96 (74%) were positive for CTX-M-15, 15 (12%) for CTX-M-14, 9 (7%) for SHV-12, 6 (5%) for CTX-M-9, 5 (4%) for CTX-M-32, and 1 (0.7%) each for CTX-M-3 and the new ESBL enzyme CTX-M-103. The 130 O25b-ST131 isolates exhibited relatively high virulence scores (mean, 14.4 virulence genes). Although the virulence profiles of the O25b-ST131 isolates were fairly homogeneous, they could be classified into four main virotypes based on the presence or absence of four distinctive virulence genes: virotypes A (22%) (afa FM955459 positive, iroN negative, ibeA negative, sat positive or negative), B (31%) (afa FM955459 negative, iroN positive, ibeA negative, sat positive or negative), C (32%) (afa FM955459 negative, iroN negative, ibeA negative, sat positive), and D (13%) (afa FM955459 negative, iroN positive or negative, ibeA positive, sat positive or negative). The four virotypes were also identified in other countries, with virotype C being overrepresented internationally. Correspondingly, an analysis of XbaI macrorestriction profiles revealed four major clusters, which were largely virotype specific. Certain epidemiological and clinical features corresponded with the virotype. Statistically significant virotype-specific associations included, for virotype B, older age and a lower frequency of infection (versus colonization), for virotype C, a higher frequency of infection, and for virotype D, younger age and community-acquired infections. In isolates of the O25b:H4-B2-ST131 clonal group, these findings uniquely define four main virotypes, which are internationally distributed, correspond with pulsed-field gel electrophoresis (PFGE) profiles, and exhibit distinctive clinical-epidemiological associations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort

Francesc Escrihuela-Vidal, Achim J. Kaasch, Maja Von Cube, Siegbert Rieg, Winfried V. Kern, Harald Seifert, Kyoung-Ho Song, Chun-Hsing Liao, Robert Tilley, Hannah Gott, Matt Scarborough, Claire Gordon, Martin J. Llewelyn, Richard Kuehl, Laura Morata, Alex Soriano, Jonathan Edgeworth, Enrique Ruiz De Gopegui, Emmanuel Nsutebu, Jose Miguel Cisneros, Vance G. Fowler, Guy Thwaites, Joaquin Lopez-Contreras, Gavin Barlow, Hugo Guillermo Ternavasio-De La Vega, Jesus Rodriguez-Bano, Luis Eduardo Lopez-Cortes

Summary: This study analysed the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection. The results showed that adherence to QCIs was associated with reduced 90-day mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Review Oncology

Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis

Elena Carrara, Elisa Razzaboni, Anna Maria Azzini, Maria Elena De Rui, Mariana Nunes Pinho Guedes, Anna Gorska, Maddalena Giannella, Linda Bussini, Michele Bartoletti, Federica Arbizzani, Zaira R. Palacios-Baena, Giulia Caponcello, Natalia Maldonado, Jesus Rodriguez-Bano, Carlo Visco, Mauro Krampera, Evelina Tacconelli

Summary: The main aim of this systematic review is to quantify the risk and identify predictors of clinical progression of SARS-CoV-2 in hematological patients compared to different control populations. The study found that hematological patients had a higher risk of COVID-19-related mortality, hospitalization, intensive-care admission, and mechanical ventilation compared to controls. Older age, male sex, and hypertension were significantly related to worse clinical outcomes in hematological patients with COVID-19.

HEMATOLOGICAL ONCOLOGY (2023)

Article Infectious Diseases

Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study

Alaa Atamna, Ili Margalit, Gida Ayada, Tanya Babich, Pontus Naucler, John Karlsson Valik, Christian G. Giske, Natividad Benito, Ruben Cardona, Alba Rivera, Celine Pulcini, Manal Abdel Fattah, Justine Haquin, Alasdair Macgowan, Bibiana Chazan, Anna Yanovskay, Ronen Ben Ami, Michal Landes, Lior Nesher, Adi Zaidman-Shimshovitz, Kate McCarthy, David L. Paterson, Evelina Tacconelli, Michael Buhl, Susanna Mauer, Jesus Rodriguez-Bano, Marina de Cueto, Antonio Oliver, Enrique Ruiz de Gopegui, Angela Cano, Isabel Machuca, Monica Gozalo-Marguello, Luis Martinez-Martinez, Eva M. Gonzalez-Barbera, Iris Gomez Alfaro, Miguel Salavert, Bojana Beovic, Andreja Saje, Manica Mueller-Premru, Leonardo Pagani, Virginie Vitrat, Diamantis Kofteridis, Maria Zacharioudaki, Sofia Maraki, Yulia Weissman, Mical Paul, Yaakov Dickstei, Dafna Yahav

Summary: This study aimed to evaluate outcomes of P. aeruginosa bacteremia among older adults (> 80 years) and found that disease severity, place of acquisition, and background conditions were associated with mortality, while antimicrobial regimen was not. Therefore, preventive efforts and early diagnosis might be beneficial for improving outcomes in older adults with P. aeruginosa bacteremia.

INFECTION (2023)

Article Medicine, General & Internal

Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis

Adi Turjeman, Elodie von Dach, Jose Molina, Erica Franceschini, Fidi Koppel, Dana Yelin, Yael Dishon-Benattar, Cristina Mussini, Jesus Rodriguez-Bano, Jose Miguel Cisneros, Angela Huttner, Mical Paul, Leonard Leibovici, Dafna Yahav

Summary: This study aims to compare the effect of short and long-term treatment in Gram-negative bacteremia on all-cause mortality in pre-specified subgroups. The results show that in patients with stable hemodynamics and normal temperature for 48 hours prior to discontinuation, seven days of antibiotic therapy for enterobacterales bacteremia result in similar outcomes as 14 days.

ECLINICALMEDICINE (2023)

Article Surgery

Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

Elena Perez-Nadales, Mario Fernandez-Ruiz, Alejandra M. Natera, Belen Gutierrez-Gutierrez, Alessandra Mularoni, Giovanna Russelli, Ligia Camera Pierrotti, Maristela Pinheiro Freire, Marco Falcone, Giusy Tiseo, Mario Tumbarello, Francesca Raffaelli, Edson Abdala, Marta Bodro, Elena Gervasi, Maria Carmen Farinas, Elena M. Seminari, Juan Jose Caston, Juan Antonio Marin-Sanz, Victor Galvez-Soto, Meenakshi M. Rana, Belen Loeches, Pilar Martin-Davila, Alvaro Pascual, Jesus Rodriguez-Bano, Jose Maria Aguado, Luis Martinez-Martinez, Julian Torre-Cisneros, REIPI INCREMENT-SOT Study Grp

Summary: This study compared the efficacy of ceftazidime-avibactam (CAZ-AVI) and the best available therapy (BAT) in treating solid organ transplant recipients with bloodstream infection caused by carbapenemase-producing Klebsiella pneumoniae. The results showed that patients treated with CAZ-AVI had higher clinical success rates at 14-day and 30-day and lower 30-day mortality compared to those receiving BAT.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Microbiology

Synergistic Effect of SOS Response and GATC Methylome Suppression on Antibiotic Stress Survival in Escherichia coli

S. Diaz-Diaz, E. Recacha, Marina R. Pulido, Maria Romero-Munoz, B. de Gregorio-Iaria, F. Docobo-Perez, A. Pascual, J. M. Rodriguez-Martinez

Summary: The suppression of the SOS response and Dam methylation system enhances the in vitro activity of quinolones. Dual targeting of the recA (SOS response) and Dam methylation system genes increases the sensitivity of Escherichia coli to quinolones, even in a resistant strain model. This genetic and microbiological approach demonstrates the potential for preventing the evolution of resistance by suppressing both systems in quinolone-resistant strains.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Infectious Diseases

Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort

Maddalena Giannella, Manuel Huth, Elda Righi, Jan Hasenauer, Lorenzo Marconi, Angelina Konnova, Akshita Gupta, An Hotterbeekx, Matilda Berkell, Zaira R. Palacios-Baena, Maria Cristina Morelli, Mariarosa Tame, Marco Busutti, Luciano Potena, Elena Salvaterra, Giuseppe Feltrin, Gino Gerosa, Lucrezia Furian, Patrizia Burra, Salvatore Piano, Umberto Cillo, Mara Cananzi, Monica Loy, Gianluigi Zaza, Francesco Onorati, Amedeo Carraro, Fiorella Gastaldon, Maurizio Nordio, Samir Kumar-Singh, Jesus Rodriguez Bano, Tiziana Lazzarotto, Pierluigi Viale, Evelina Tacconelli

Summary: This study aimed to assess the predictors of negative antibody response in solid organ transplant recipients after the first booster of SARS-CoV-2 vaccination. Machine learning models and clinical data were used to identify age, type of transplant, time between transplant and vaccination, immunosuppressive drugs, type of vaccine, and graft function as significant predictors of negative antibody response. This study is of significant importance for improving vaccination strategies in solid organ transplant recipients.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Infectious Diseases

Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

Jesus Sojo-Dorado, Inmaculada Lopez-Hernandez, Alicia Hernandez-Torres, Pilar Retamar-Gentil, Esperanza Merino de Lucas, Laura Escola-Verge, Elena Bereciartua, Elisa Garcia-Vazquez, Vicente Pintado, Lucia Boix-Palop, Clara Natera-Kindelan, Luisa Sorli, Nuria Borrell, Concha Amador-Prous, Evelyn Shaw, Alfredo Jover-Saenz, Jose Molina, Rosa M. Martinez-Alvarez, Carlos J. Duenas, Jorge Calvo-Montes, Maria Lecuona, Virginia Pomar, Irene Borreguero, Virginia Palomo-Jimenez, Fernando Docobo-Perez, Alvaro Pascual, Jesus Rodriguez-Bano

Summary: This study compared the effectiveness and safety of fosfomycin trometamol and other oral drugs as step-down therapy for multidrug-resistant Escherichia coli (MDR-Ec) induced bacteremic urinary tract infections (BUTI). The results showed no significant difference in clinical and microbiological cure between fosfomycin trometamol and other drugs, but the relapse rate was higher in the fosfomycin trometamol group. Therefore, fosfomycin trometamol may be a reasonable option for step-down therapy in BUTI, but the relapse rate needs further evaluation.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Medicine, General & Internal

Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers

Laure F. Pittet, Nicole L. Messina, Francesca Orsini, Cecilia L. Moore, Veronica Abruzzo, Simone Barry, Rhian Bonnici, Marc Bonten, John Campbell, Julio Croda, Margareth Dalcolmo, Kaya Gardiner, Grace Gell, Susie Germano, Adriano Gomes-Silva, Casey Goodall, Amanda Gwee, Tenaya Jamieson, Bruno Jardim, Tobias R. Kollmann, Marcus V. G. Lacerda, Katherine J. Lee, Michaela Lucas, David J. Lynn, Laurens Manning, Helen S. Marshall, Ellie McDonald, Craig F. Munns, Suellen Nicholson, Abby O'Connell, Roberto D. de Oliveira, Susan Perlen, Kirsten P. Perrett, Cristina Prat-Aymerich, Peter C. Richmond, Jesus Rodriguez-Bano, Glauce dos Santos, Patricia V. da Silva, Jia Wei Teo, Paola Villanueva, Adilia Warris, Nicholas J. Wood, Andrew Davidson, Nigel Curtis

Summary: In this international trial, healthcare workers were randomly assigned to receive either the BCG-Denmark vaccine or a saline placebo. After 6 months, it was found that the BCG vaccine did not reduce the risk of symptomatic or severe Covid-19 compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Multidisciplinary Sciences

Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM): Protocol for a randomized, pragmatic trial

Carmen Garrigos, Clara Maria Rosso-Fernandez, Irene Borreguero, Patricia Rodriguez, Raquel Garcia-Albea, Jose Maria Bravo-Ferrer, Jesus Rodriguez-Bano, Maria Dolores del Toro

Summary: This study aims to investigate the optimal duration of antibiotic treatment in infection associated with osteosynthesis material (IOM) after long bone fractures. The hypothesis is that a shorter duration of antibiotic treatment can reduce antibiotic exposure, control antimicrobial resistance, and lower adverse events and costs, while still maintaining a high cure rate and functional recovery.

PLOS ONE (2023)

Article Microbiology

Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated blaIMI-6 Gene

T. Blanco-Martin, J. Guzman-Puche, C. Riazzo, M. Gasca-Santiyan, M. Hernandez-Garcia, R. Canton, J. Torre-Cisneros, C. Herrera, L. Martinez-Martinez

Summary: IMI carbapenemases confer an unusual resistance pattern, making them difficult to detect. Commercial molecular methods usually do not include bla(IMI) genes, contributing to the hidden dissemination of bacteria producing these enzymes. We report a plasmid-encoded IMI-6 carbapenemase in an Enterobacter ludwigii isolate, providing insights into its genetic characteristics.

MICROBIOLOGY SPECTRUM (2023)

Article Infectious Diseases

Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?

Beatriz Fernandez-Rubio, Laura Herrera-Hidalgo, Luis E. Lopez-Cortes, Rafael Luque-Marquez, Aristides De Alarcon, Sonia Luque-Pardos, Aurora Fernandez-Polo, Jose Maria Gutierrez-Urbon, Jesus Rodriguez-Bano, Maria Victoria Gil-Navarro, Alicia Gutierrez-Valencia

Summary: This study evaluated the physical and chemical stability of temocillin at different temperatures and stored in different containers at the recommended dose for OPAT. It was found that temocillin is stable under OPAT conditions and can be an appropriate treatment option for patients. A novel LC-MS/MS method was also developed for the quantification of temocillin.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Infectious Diseases

Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48

Irene Sanchez-Leon, Teresa Garcia-Martinez, Seydina M. Diene, Elena Perez-Nadales, Luis Martinez-Martinez, Jean-Marc Rolain

Summary: This study aimed to investigate heteroresistance in nine clinical isolates of Klebsiella pneumoniae producing OXA-48 and describe genomic changes in vitro. It was found that the heteroresistance in K. pneumoniae isolates was mainly attributed to insertions in the mgrB gene and point mutations in colistin resistance proteins. These findings contribute to the understanding of colistin resistance mechanisms in OXA-48-producing K. pneumoniae mutants.

ANTIBIOTICS-BASEL (2023)

Article Veterinary Sciences

Effect of phage vB_EcoM_FJ1 on the reduction of ETEC O9:H9 infection in a neonatal pig cell line

Alice Ferreira, Daniela Silva, Carina Almeida, Maria Elisa Rodrigues, Sonia Silva, Joana Castro, Dalila Mil-Homens, Isidro Garcia-Menino, Azucena Mora, Mariana Henriques, Ana Oliveira

Summary: This study evaluated the efficacy of phage vB_EcoM_FJ1 (FJ1) in reducing the load of pathogenic Escherichia coli (ETEC) and found that encapsulated FJ1 in microparticles significantly reduced the quantity of ETEC. Bacteriophage-insensitive mutants (BIMs) displayed weaker adaptability in the pig model.

VETERINARY RESEARCH (2023)

Article Microbiology

Heteroresistance to colistin in wild-type Klebsiella pneumoniae isolates from clinical origin

Irene Sanchez-Leon, Elena Perez-Nadales, Juan Antonio Marin-Sanz, Teresa Garcia-Martinez, Luis Martinez-Martinez

Summary: This study investigated heteroresistance in 10 wild-type Klebsiella pneumoniae isolates of clinical origin. The results showed the importance of persistent variants and stable mutants in heteroresistance, and described the genomic changes observed in mutants obtained in population analysis profiling (PAP) assays.

MICROBIOLOGY SPECTRUM (2023)

暂无数据